Tarlatamab Before and After Surgery for Recurrent High-Grade Glioma

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-524359-30-00

Enrollment

Registered

2026-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

surgically resectable recurrent high-grade glioma

None listed

Sex/Gender

All

Age

18 Years to No maximum

None listed

Source: EU CTIS · Data processed: Jul 23, 2026